National HealthCare Corporation
$166.58
▲
3.03%
2026-04-21 08:24:00
www.nhccare.com
ASE: NHC
Explore National HealthCare Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.6 B
Current Price
$166.58
52W High / Low
$177.47 / $89.4
Stock P/E
21.66
Book Value
$68.79
Dividend Yield
1.54%
ROCE
10.08%
ROE
11.92%
Face Value
—
EPS
$7.67
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
15,278
Beta
0.59
Debt / Equity
8.1
Current Ratio
1.82
Quick Ratio
1.79
Forward P/E
397.33
Price / Sales
1.76
Enterprise Value
$2.49 B
EV / EBITDA
14.38
EV / Revenue
1.64
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | biote Corp. | $2.24 | 3.25 | $87.8 M | — | 56.77% | -32.89% | $4.75 / $1.27 | $-1.91 |
| 2. | Cryo-Cell International, Inc. | $3.56 | — | $27.71 M | 11.63% | 11.54% | 15.27% | $6.35 / $2.72 | $-2.31 |
| 3. | Option Care Health, Inc. | $28.77 | 21.68 | $4.5 B | — | 12.87% | 15.2% | $36.8 / $24.24 | $8.46 |
| 4. | Strata Critical Medical, Inc. | $4.52 | 9.61 | $397.54 M | — | -7.31% | -8.01% | $6.02 / $2.51 | $4.18 |
| 5. | Surgery Partners, Inc. | $14.31 | — | $1.85 B | — | 6.27% | 2.76% | $24.18 / $11.41 | $13.37 |
| 6. | P3 Health Partners Inc. | $2.83 | — | $18.75 M | — | -242.67% | -69.53% | $11.3 / $1.52 | $-47.24 |
| 7. | Addus HomeCare Corporation | $93.52 | 18.23 | $1.75 B | — | 10.76% | 9.33% | $124.44 / $90.89 | $59.84 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 386.51 M | 382.66 M | 374.91 M | 373.7 M | 369.35 M |
| Operating Profit | 33.12 M | 30.38 M | 34.09 M | 30.77 M | 28.91 M |
| Net Profit | 24.85 M | 39.24 M | 23.72 M | 32.2 M | 6.08 M |
| EPS in Rs | 1.59 | 2.52 | 1.52 | 2.06 | 0.39 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.52 B | 1.3 B | 1.14 B | 1.07 B |
| Operating Profit | 128.35 M | 89.89 M | 57.46 M | 28.73 M |
| Net Profit | 120.02 M | 101.93 M | 66.8 M | 22.45 M |
| EPS in Rs | 7.69 | 6.53 | 4.28 | 1.44 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.53 B | 1.52 B | 1.31 B | 1.28 B |
| Total Liabilities | 451.9 M | 541.27 M | 400.32 M | 397.94 M |
| Equity | 1.07 B | 980.16 M | 908.75 M | 874.28 M |
| Current Assets | 461.82 M | 424.41 M | 406.24 M | 353.93 M |
| Current Liabilities | 253.63 M | 234.8 M | 214.48 M | 197.89 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 185.08 M | 107.3 M | 111.22 M | 8.74 M |
| Investing CF | -33.86 M | -236.69 M | -17.57 M | -5.98 M |
| Financing CF | -135.96 M | 100.34 M | -42.55 M | -47.64 M |
| Free CF | 148.63 M | 79.7 M | 83.31 M | -21.46 M |
| Capex | -36.45 M | -27.6 M | -27.9 M | -30.2 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 13.7% | 6.26% | — | — |
| Earnings Growth % | 52.59% | 197.61% | — | — |
| Profit Margin % | 7.85% | 5.85% | 2.09% | — |
| Operating Margin % | 6.93% | 5.03% | 2.67% | — |
| Gross Margin % | 37.52% | 37.6% | 36.13% | — |
| EBITDA Margin % | 14.06% | 11.48% | 6.36% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-31 | $0.64 |
| 2025-12-31 | $0.64 |
| 2025-09-30 | $0.64 |
| 2025-06-30 | $0.64 |
| 2025-03-28 | $0.61 |
Stock Splits
No stock split history available.